Ledger.Open graph →
SEC Form D · filed February 11, 2019

Solace Therapeutics Inc

Offering
$2.1M
Sold
$1.9M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
FRAMINGHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

William H. Gruber · Framingham, MAExec · DirectorJohn R. Mcdonough · Framingham, MADirectorKevin G. Connors · Framingham, MAExec · DirectorRyan G. Drant · Framingham, MADirectorAli G. Behbahani · Framingham, MADirectorStacy G. Enxing Seng · Framingham, MADirectorRyan B. Hanks · Charlotte, NCExec · DirectorLivya A. Antonacci · Bethesda, MDExec · DirectorDonna J. Wagner · Bethesda, MDDirectorJason Georgatos · Tiburon, CAExec · DirectorAndrew Kahn · Tiburon, CADirectorArmineh Baghoomian · Tiburon, CAExec · DirectorRyan G. Drant · Framingham, MADirectorAli G. Behbahani · Framingham, MADirectorStacy G. Enxing Seng · Framingham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗